Biotech-Stock Mailbag: Amgen, MiddleBrook
Examining Amgen's discount; updating MiddleBrook; valuing Seattle Genetics; and comparing SuperGen to Celgene. 2 months ago
TheStreet Click here to Read the Full Story
Digg
del.icio.us
Reddit
Stumble
Newsvine
FacebookHome|About| 
Subscribe to RSS feeds|Product Blog|Contact|Site Map|Help
Copyright© 2008 nobosh LLC. All Rights Reserved